Adragos Pharma News and Resources

Adragos Pharma, a contract development and manufacturing organisation (CDMO), has completed a €13 million ($13.8 million) investment at its Livron-sur-Drôme site in France. The enhancement includes a new ampoule filling line and a state-of-the-art cleanroom, increasing the facility’s output by